Zhu H - Search Results

1

17-Hydroxy Wortmannin Restores TRAIL's Response by Ameliorating Increased Beclin 1 Level and Autophagy Function in TRAIL-Resistant Colon Cancer Cells.

Dai S, Yang S, Hu X, Sun W, Tawa G, Zhu W, Schimmer AD, He C, Fang B, Zhu H, Zheng W. Dai S, et al. Among authors: zhu w, zhu h. Mol Cancer Ther. 2019 Jul;18(7):1265-1277. doi: 10.1158/1535-7163.MCT-18-1241. Epub 2019 May 15. Mol Cancer Ther. 2019. PMID: 31092562 Free PMC article.

2

Lack of p38 MAP kinase activation in TRAIL-resistant cells is not related to the resistance to TRAIL-mediated cell death.

Zhang L, Zhu H, Davis JJ, Jacob D, Wu S, Teraishi F, Gutierrez A, Wang Y, Fang B. Zhang L, et al. Among authors: zhu h. Cancer Biol Ther. 2004 Mar;3(3):296-301. doi: 10.4161/cbt.3.3.696. Epub 2004 Mar 16. Cancer Biol Ther. 2004. PMID: 14749540 Free article.

3

Induction of apoptosis and down-regulation of Bcl-XL in cancer cells by a novel small molecule, 2[[3-(2,3-dichlorophenoxy)propyl]amino]ethanol.

Wu S, Zhu H, Gu J, Zhang L, Teraishi F, Davis JJ, Jacob DA, Fang B. Wu S, et al. Among authors: zhu h. Cancer Res. 2004 Feb 1;64(3):1110-3. doi: 10.1158/0008-5472.can-03-2790. Cancer Res. 2004. PMID: 14871845

4

Overcoming acquired resistance to TRAIL by chemotherapeutic agents and calpain inhibitor I through distinct mechanisms.

Zhu H, Zhang L, Huang X, Davis JJ, Jacob DA, Teraishi F, Chiao P, Fang B. Zhu H, et al. Mol Ther. 2004 May;9(5):666-73. doi: 10.1016/j.ymthe.2004.02.007. Mol Ther. 2004. PMID: 15120327 Free article.

5

Induction of S-phase arrest and p21 overexpression by a small molecule 2[[3-(2,3-dichlorophenoxy)propyl] amino]ethanol in correlation with activation of ERK.

Zhu H, Zhang L, Wu S, Teraishi F, Davis JJ, Jacob D, Fang B. Zhu H, et al. Oncogene. 2004 Jun 24;23(29):4984-92. doi: 10.1038/sj.onc.1207645. Oncogene. 2004. PMID: 15122344

6

Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.

Jacob D, Davis J, Zhu H, Zhang L, Teraishi F, Wu S, Marini FC 3rd, Fang B. Jacob D, et al. Among authors: zhu h. Clin Cancer Res. 2004 May 15;10(10):3535-41. doi: 10.1158/1078-0432.CCR-03-0512. Clin Cancer Res. 2004. PMID: 15161713

7

Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter.

Jacob D, Davis JJ, Zhang L, Zhu H, Teraishi F, Fang B. Jacob D, et al. Among authors: zhu h. Cancer Gene Ther. 2005 Feb;12(2):109-15. doi: 10.1038/sj.cgt.7700773. Cancer Gene Ther. 2005. PMID: 15486557

8

Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells.

Zhu H, Guo W, Zhang L, Davis JJ, Teraishi F, Wu S, Cao X, Daniel J, Smythe WR, Fang B. Zhu H, et al. Mol Cancer Ther. 2005 Mar;4(3):451-6. doi: 10.1158/1535-7163.MCT-04-0162. Mol Cancer Ther. 2005. PMID: 15767554

9

Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors.

Zhu H, Zhang L, Dong F, Guo W, Wu S, Teraishi F, Davis JJ, Chiao PJ, Fang B. Zhu H, et al. Oncogene. 2005 Jul 21;24(31):4993-9. doi: 10.1038/sj.onc.1208683. Oncogene. 2005. PMID: 15824729 Free PMC article.

10

P-glycoprotein-independent apoptosis induction by a novel synthetic compound, MMPT [5-[(4-methylphenyl)methylene]-2-(phenylamino)-4(5H)-thiazolone].

Teraishi F, Wu S, Sasaki J, Zhang L, Zhu HB, Davis JJ, Fang B. Teraishi F, et al. J Pharmacol Exp Ther. 2005 Jul;314(1):355-62. doi: 10.1124/jpet.105.085654. Epub 2005 Apr 14. J Pharmacol Exp Ther. 2005. PMID: 15831436

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,845 results

Search Page

Filters